Michael S. Rafii

Affiliations: 
2008-2016 Neuroscience University of California, San Diego, La Jolla, CA 
 2016- Neurology University of Southern California Keck School of Medicine 
Area:
Neurodegenerative Diseases
Google:
"Michael Rafii"
Mean distance: 15.77 (cluster 11)
 
SNBCP

Parents

Sign in to add mentor
Justin R. Fallon grad student 1997-2002 Brown
 (Roles for the proteoglycan biglycan in muscular dystrophy and neuromuscular junction formation.)
Leon J. Thal post-doc 2006-2008 UCSD
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

van Dyck CH, Nygaard HB, Chen K, et al. (2019) Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial. Jama Neurology
Iddi S, Li D, Aisen PS, et al. (2019) Predicting the course of Alzheimer's progression. Brain Informatics. 6: 6
Rafii MS, Donohue MC, Matthews DC, et al. (2019) Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). Journal of Alzheimer's Disease : Jad
Rafii MS, Aisen PS. (2018) Alzheimer's Disease Clinical Trials: Moving Toward Successful Prevention. Cns Drugs
Li D, Iddi S, Thompson WK, et al. (2018) Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 657-668
Rafii MS, Tuszynski MH, Thomas RG, et al. (2018) Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial. Jama Neurology
Rafii MS, Lukic AS, Andrews RD, et al. (2017) PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). Journal of Alzheimer's Disease : Jad. 60: 439-450
Relkin NR, Thomas RG, Rissman RA, et al. (2017) A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology
Matthews DC, Lukic AS, Andrews RD, et al. (2016) Dissociation of Down syndrome and Alzheimer's disease effects with imaging. Alzheimer's & Dementia (New York, N. Y.). 2: 69-81
Rafii MS. (2016) Improving Memory and Cognition in Individuals with Down Syndrome. Cns Drugs
See more...